c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells
Kun Wu1, Yan Zhao, Gui-Chang Li
1Department of Nutrition and Food Hygiene, Public Health School, Harbin Medical University, Harbin 150001, Heilongjiang Province, China. wukun@public.hr.hl.cn
Aim:
To investigate the roles of c-Jun N-terminal kinase (JNK) signaling pathway in vitamin E succinate-induced apoptosis in human gastric cancer SGC-7901 cells.
Methods:
Human gastric cancer cell lines (SGC-7901) were treated with vitamin E succinate (VES) at 5, 10, 20 mg/L. Succinic acid and vitamin E were used as vehicle controls and condition medium only as an untreated (UT) control. Apoptosis was observed by 4', 6-diamidine-2'-phenylindole dihydrochloride (DAPI) staining for morphological changes and by DNA fragmentation for biochemical alterations. Western blot analysis was applied to measure the expression of JNK and phosphorylated JNK. After the cells were transiently transfected with dominant negative mutant of JNK (DN-JNK) followed by treatment of VES, the expression of JNK and c-Jun protein was determined.
Results:
The apoptotic changes were observed after VES treatment by DNA fragmentation. DNA ladder in the 20 mg/L VES group was more clearly seen than that in 10 mg/L VES group and was not detected following treatment of UT control, succinate and vitamin E. VES at 5, 10 and 20 mg/L increased the expression of p-JNK by 2.5-, 2.8- and 4.2-fold, respectively. VES induced the phosphorylation of JNK beginning at 1.5 h and produced a sustained increase for 24 h with the peak level at 12 h. Transient transfection of DN-JNK blocked VES-triggered apoptosis by 52%. DN-JNK significantly increased the level of JNK, while decreasing the expression of VES-induced c-Jun protein.
Conclusion:
VES-induced apoptosis in human gastric cancer SGC-7901 cells involves JNK signaling pathway via c-Jun and its downstream transcription factor.
Insights
Vitamin E succinate (VES) induces apoptosis in gastric cancer cells by activating the c-Jun N-terminal kinase (JNK) pathway. This pathway involves c-Jun, highlighting a potential therapeutic target for gastric cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Gastric cancer remains a significant global health challenge.
- Identifying novel therapeutic agents and understanding their mechanisms of action are crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the role of the c-Jun N-terminal kinase (JNK) signaling pathway in vitamin E succinate (VES)-induced apoptosis.
- To elucidate the molecular mechanisms by which VES triggers cell death in human gastric cancer SGC-7901 cells.
Main Methods:
- Human gastric cancer SGC-7901 cells were treated with varying concentrations of VES.
- Apoptosis was assessed using DAPI staining and DNA fragmentation assays.
- Western blot analysis was employed to measure JNK and phosphorylated JNK (p-JNK) expression.
- The impact of dominant-negative JNK (DN-JNK) transfection on VES-induced apoptosis and c-Jun expression was evaluated.
Main Results:
- VES treatment induced significant DNA fragmentation, indicative of apoptosis, in a dose-dependent manner.
- VES markedly increased the phosphorylation of JNK, with a sustained elevation observed over 24 hours.
- Transfection with DN-JNK partially blocked VES-induced apoptosis and modulated JNK and c-Jun protein levels.
Conclusions:
- The JNK signaling pathway plays a critical role in VES-induced apoptosis in human gastric cancer cells.
- VES-induced apoptosis is mediated through the JNK pathway, involving c-Jun and its downstream targets.
- These findings suggest that VES and the JNK pathway represent a promising therapeutic strategy for gastric cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Extrinsic Apoptotic Pathway
